{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:12:21Z","timestamp":1753891941622,"version":"3.41.2"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Translational medical research on hepatitis B virus (HBV) infection and chronic hepatitis B (CHB) pathogenesis provides guidance on strengthening the treatment and prevention strategies of CHB. Preventing vertical transmission is the key to eliminating HBV infection in children. The understanding of HBV replication, hepatocyte turnover, and the fate of covalently closed circular DNA (cccDNA) would help establish a personalized application of the guidelines, especially concerning the discontinuation of nucleos(t)ide analog (NA) treatment in children. Transplacental leakage of HBV-infected maternal blood is suggested as the leading cause of vertical transmission. Prenatal maternal prophylaxis could diminish maternal HBV viremia at delivery, to reduce the risk of neonatal HBV infection. The meaning of the expression \u201cno additional risk of breast milk feeding\u201d is thereby explained. Understanding the untreated natural course of CHB in children and the course changeable by treatment is important to apply individualistic strategies and avoid the immoral selection of treatment indications. NAs with potent efficacy and a high barrier to drug resistance should be used as first-line treatment to reduce the likelihood of NA-resistant HBV development because the rate of mutant HBV emergence might count on the infected hepatocyte turnover rate in chronic HBV infection. Although elimination of intranuclear cccDNA is difficult by NAs alone, a cure is possible by human immunity and hepatocyte turnover. The reduction of intranuclear cccDNA occurs after the destruction of HBV-infected hepatocytes, non-cytolytic immune response, apoptosis of hepatocytes, and compensatory cell proliferation. Therefore, consolidation therapy after NA-induced hepatitis B e-antigen seroconversion must be necessary for a sufficient period. This review also summarizes the treatment strategies of CHB in children based on the practical application of translational research.<\/jats:p>","DOI":"10.3389\/fped.2021.809838","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T07:04:01Z","timestamp":1643958241000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries"],"prefix":"10.3389","volume":"9","author":[{"given":"Ben","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Yong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Ho","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1002\/cncr.30237","article-title":"Comparison of hepatocellular carcinoma in Eastern versus Western populations","volume":"122","author":"Choo","year":"2016","journal-title":"Cancer."},{"key":"B2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jpeds.2003.11.022","article-title":"The development of hepatocellular carcinoma among prospectively followed children with chronic hepatitis B virus infection","volume":"144","author":"Wen","year":"2004","journal-title":"J Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.3760\/cma.j.issn.0366-6999.2011.24.011","article-title":"Characterization of hepatitis B virus genotypes\/subgenotypes in 1,301 patients with chronic hepatitis B in North China","volume":"124","author":"Li","year":"2011","journal-title":"Chin Med J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3904\/kjim.2011.26.3.255","article-title":"Molecular epidemiology of hepatitis B virus","volume":"26","author":"Kao","year":"2011","journal-title":"Korean J Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1053\/j.gastro.2004.09.048","article-title":"Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma","volume":"127","author":"Ni","year":"2004","journal-title":"Gastroenterology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address eee, European Association for the Study of the L. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol."},{"key":"B7","first-page":"14","article-title":"Immunopathology of chronic viral hepatitis","volume":"38","author":"Desmet","year":"1991","journal-title":"Hepatogastroenterology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.3346\/jkms.2018.33.e69","article-title":"What are the main differences in the treatment of chronic hepatitis B between Korean children and adults?","volume":"33","author":"Choe","year":"2018","journal-title":"J Korean Med Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.1840220508","article-title":"The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age","volume":"22","author":"Chang","year":"1995","journal-title":"Hepatology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.3748\/wjg.v20.i13.3582","article-title":"What physicians should know about the management of chronic hepatitis B in children: east side story","volume":"20","author":"Choe","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3904\/kjim.2014.29.3.296","article-title":"A disappearing vertical infection: will hepatitis B be a forgotten disease in children?","volume":"29","author":"Choe","year":"2014","journal-title":"Korean J Intern Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3904\/kjim.2013.28.4.413","article-title":"Recent trends in hepatitis B virus infection in the general Korean population","volume":"28","author":"Kim","year":"2013","journal-title":"Korean J Intern Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1056\/NEJMoa1508660","article-title":"Tenofovir to prevent hepatitis B transmission in mothers with high viral load","volume":"374","author":"Pan","year":"2016","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","article-title":"Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers","volume":"19","author":"Zou","year":"2012","journal-title":"J Viral Hepat."},{"key":"B15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0022-3476(87)80210-X","article-title":"Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus","volume":"111","author":"Lin","year":"1987","journal-title":"J Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.3748\/wjg.v13.i26.3625","article-title":"Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism","volume":"13","author":"Bai","year":"2007","journal-title":"World J Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1128\/AAC.00514-10","article-title":"Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2","volume":"55","author":"Benaboud","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1203\/00006450-198203000-00017","article-title":"Maternofetal transmission of IgG-bound hepatitis B e antigen","volume":"16","author":"Arakawa","year":"1982","journal-title":"Pediatr Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.14218\/JCTH.2016.00067","article-title":"Mechanisms and prevention of vertical transmission in chronic viral hepatitis","volume":"5","author":"Mavilia","year":"2017","journal-title":"J Clin Transl Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.cgh.2013.04.026","article-title":"Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants","volume":"11","author":"Pan","year":"2013","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jinf.2012.12.008","article-title":"Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus","volume":"66","author":"Yin","year":"2013","journal-title":"J Infect."},{"key":"B22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jhep.2009.10.031","article-title":"The replication cycle of hepatitis B virus","volume":"52","author":"Urban","year":"2010","journal-title":"J Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","article-title":"Hepatitis B virus biology and life cycle","volume":"182","author":"Tsukuda","year":"2020","journal-title":"Antiviral Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.193.7.847","article-title":"Kinetics of acute hepatitis B virus infection in humans","volume":"193","author":"Whalley","year":"2001","journal-title":"J Exp Med."},{"key":"B25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/135965359800300404","article-title":"Hepatitis B virus antiviral drug resistance: from the laboratory to the patient","volume":"3","author":"Mutimer","year":"1998","journal-title":"Antivir Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hep.23611","article-title":"In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice","volume":"52","author":"Lutgehetmann","year":"2010","journal-title":"Hepatology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","article-title":"Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo","volume":"67","author":"Allweiss","year":"2018","journal-title":"Gut."},{"key":"B28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jhep.2019.04.010","article-title":"Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells","volume":"71","author":"Konig","year":"2019","journal-title":"J Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jhep.2004.12.015","article-title":"New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA","volume":"42","author":"Zoulim","year":"2005","journal-title":"J Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"veaa063","DOI":"10.1093\/ve\/veaa063","article-title":"Estimating hepatitis B virus cccDNA persistence in chronic infection","volume":"7","author":"Lythgoe","year":"2021","journal-title":"Virus Evol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/hep.21282","article-title":"Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B","volume":"44","author":"Wursthorn","year":"2006","journal-title":"Hepatology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.3748\/wjg.v19.i40.6757","article-title":"Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure","volume":"19","author":"Esrefoglu","year":"2013","journal-title":"World J Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1034\/j.1600-0676.2002.01702.x","article-title":"Cell proliferation and renewal of normal hepatocytes and bile duct cells in adult mouse liver","volume":"22","author":"Magami","year":"2002","journal-title":"Liver."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1073\/pnas.0409332102","article-title":"Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection","volume":"102","author":"Mason","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"12372","DOI":"10.1073\/pnas.2033898100","article-title":"Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver","volume":"100","author":"Zhang","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1092066","article-title":"Inhibition of hepatitis B virus replication by APOBEC3G","volume":"303","author":"Turelli","year":"2004","journal-title":"Science."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/S0168-8278(03)00137-5","article-title":"Immunopathogenesis of hepatitis B","volume":"39","author":"Ferrari","year":"2003","journal-title":"J Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1111\/hepr.12533","article-title":"Hepatic flares promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance: a long-term follow-up study","volume":"46","author":"Nagaoka","year":"2016","journal-title":"Hepatol Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/01.mpg.0000243439.47334.4e","article-title":"Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better","volume":"44","author":"Choe","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3350\/kjhep.2009.15.2.168","article-title":"Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B","volume":"15","author":"Kim","year":"2009","journal-title":"Korean J Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/jvh.12007","article-title":"Cure for immune-tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon?","volume":"20","author":"Poddar","year":"2013","journal-title":"J Viral Hepat."},{"key":"B44","first-page":"S199","article-title":"Long-term efficacy and safety of Tenofovir Disoproxil Fumarate (TDF) in children with Chronic Hepatitis B (CHB): final results from a placebo-controlled trial","volume":"75","author":"Chang","year":"2021","journal-title":"J Hepatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3350\/cmh.2019.1002","article-title":"KASL clinical practice guidelines for management of chronic hepatitis B","volume":"25","year":"2019","journal-title":"Clin Mol Hepato."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int."},{"key":"B47","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.1128\/jvi.68.12.8321-8330.1994","article-title":"Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks","volume":"68","author":"Fourel","year":"1994","journal-title":"J Virol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"336","DOI":"10.21037\/atm.2016.09.06","article-title":"Treatment strategies according to genotype for chronic hepatitis B in children","volume":"4","author":"Cho","year":"2016","journal-title":"Ann Transl Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/gast.2002.33588","article-title":"Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C","volume":"122","author":"Chu","year":"2002","journal-title":"Gastroenterology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2893.2006.00810.x","article-title":"Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion","volume":"14","author":"Chu","year":"2007","journal-title":"J Viral Hepat."},{"key":"B51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5223\/pghn.2014.17.1.41","article-title":"The Rate of conversion from immune-tolerant phase to early immune-clearance phase in children with chronic hepatitis B virus infection","volume":"17","author":"Hong","year":"2014","journal-title":"Pediatr Gastroenterol Hepatol Nutr."},{"key":"B52","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3350\/cmh.2020.0324","article-title":"Old hepatitis B virus never dies: it just hides itself within the host genome","volume":"27","author":"Lee","year":"2021","journal-title":"Clin Mol Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2014.10.038","article-title":"American gastroenterological association institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Perrillo","year":"2015","journal-title":"Gastroenterology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3350\/cmh.2020.0049","article-title":"Comparison of clinical practice guidelines for the management of chronic hepatitis B: when to start, when to change, and when to stop","volume":"26","author":"Yim","year":"2020","journal-title":"Clin Mol Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/hep.28438","article-title":"Discontinuation of oral antivirals in chronic hepatitis B: a systematic review","volume":"63","author":"Papatheodoridis","year":"2016","journal-title":"Hepatology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/liv.12735","article-title":"HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients","volume":"35","author":"Martinot-Peignoux","year":"2015","journal-title":"Liver Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jinf.2021.08.044","article-title":"On-treatment HBV RNA dynamic predicts entecavir-induced HBeAg seroconversion in children with chronic hepatitis B: HBV RNA predicts HBeAg seroconversion","volume":"83","author":"Wu","year":"2021","journal-title":"J Infect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12985-020-01471-2","article-title":"Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment","volume":"18","author":"Wang","year":"2021","journal-title":"Virol J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1111\/jgh.15516","article-title":"Novel viral markers and the prediction of off-treatment relapse in chronic hepatitis B patients: a systematic review","volume":"36","author":"Jaroenlapnopparat","year":"2021","journal-title":"J Gastroenterol Hepatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.4254\/wjh.v8.i34.1511","article-title":"On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B","volume":"8","author":"Gao","year":"2016","journal-title":"World J Hepatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3350\/cmh.2016.0047","article-title":"Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B","volume":"22","author":"Lee","year":"2016","journal-title":"Clin Mol Hepatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e0188303","DOI":"10.1371\/journal.pone.0188303","article-title":"Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues","volume":"12","author":"Broquetas","year":"2017","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.809838\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T20:34:54Z","timestamp":1674678894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.809838\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,4]]},"references-count":62,"alternative-id":["10.3389\/fped.2021.809838"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.809838","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2022,2,4]]},"article-number":"809838"}}